Articles By Anuja Singh

Regeneron to Present at 44th Annual J.P. Morgan Healthcare Conference

TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its presentation at the…

ByByAnuja Singh Dec 25, 2025
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including Regained Strength and Extended Survival

Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical Association (JAMA) Neurology…

ByByAnuja Singh Dec 25, 2025
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?

Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…

ByByAnuja Singh Dec 25, 2025
Is Samsung Biologics Set to Expand U.S. Operations with $280 Million GSK Acquisition?

Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug production facility from…

ByByAnuja Singh Dec 25, 2025
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?

Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…

ByByAnuja Singh Dec 25, 2025
Is McRae Tech Setting a New Standard for Scalable AI in Healthcare with Its…

McRae Tech has introduced Orchestral, a health-focused AI orchestrator data platform designed to support large-scale, governed use of…

ByByAnuja Singh Dec 25, 2025
Image Not Found
Regeneron to Present at 44th Annual J.P. Morgan Healthcare Conference

TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its presentation at the…

ByByAnuja Singh Dec 25, 2025
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including Regained Strength and Extended Survival

Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical Association (JAMA) Neurology…

ByByAnuja Singh Dec 25, 2025
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?

Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…

ByByAnuja Singh Dec 25, 2025
Is Samsung Biologics Set to Expand U.S. Operations with $280 Million GSK Acquisition?

Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug production facility from…

ByByAnuja Singh Dec 25, 2025
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?

Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…

ByByAnuja Singh Dec 25, 2025
Is McRae Tech Setting a New Standard for Scalable AI in Healthcare with Its…

McRae Tech has introduced Orchestral, a health-focused AI orchestrator data platform designed to support large-scale, governed use of…

ByByAnuja Singh Dec 25, 2025
Scroll to Top